This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
Home » Clues to opioid abuse from state prescription drug monitoring programs
Drug overdose is the leading cause of injury death in the United States – mostly due to abuse and misuse of prescription opioid pain relievers, benzodiazepines (sedatives/tranquilizers), and stimulants. Information from state prescription drug monitoring programs (PDMPs) can be used to detect and measure prescribing patterns that suggest abuse and misuse of controlled substances, according to a report released today in the Centers for Disease Control and Prevention’s (CDC) Morbidity and Mortality Weekly Report (MMWR) Surveillance Summary.
It is the first multi-state report from the CDC- and FDA-funded Prescription Behavior Surveillance System (PBSS), which analyzes data from state PDMPs. The eight states that submitted 2013 data—California, Delaware, Florida, Idaho, Louisiana, Maine, Ohio and West Virginia—represent about a quarter of the U.S. population.